David A. Eberhard
Impact in
-
- Lung Cancer Treatments and Mutations
- Genetics top 2%
- Glioma Diagnosis and Treatment
Papers in
-
- Cancer Genomics and Diagnostics 9
- Breast Cancer Treatment Studies 3
-
- Lung Cancer Treatments and Mutations 8
- Co-authors
- Ronald W. Holz (6 shared papers)Bruce Evan Johnson (3 shared papers)Somasekar Seshagiri (4 shared papers)Lukas C. Amler (2 shared papers)Thomas Januario (2 shared papers)Jeremy Stinson (3 shared papers)Ladislau E. Steiner (2 shared papers)Roy S. Herbst (3 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Clinical Cancer Research (3 papers)Applied immunohistochemistry & molecular morphology (3 papers)Nature (2 papers)Biochemical Journal (2 papers)
- Partner nations
- United StatesCanadaIreland
In The Last Decade
David A. Eberhard
51 papers receiving 6.8k citations
David A. Eberhard's Hit Papers
Peers
Comparison fields: 5 of 119
- Pulmonary and Respiratory Medicine 2.1k
- Genetics 447
- Cancer Research 666
- Oncology 1.1k
- Cell Biology 455
Countries citing papers authored by David A. Eberhard
This map shows the geographic impact of David A. Eberhard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Eberhard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Eberhard more than expected).
Fields of papers citing papers by David A. Eberhard
This network shows the impact of papers produced by David A. Eberhard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Eberhard. The network helps show where David A. Eberhard may publish in the future.
Co-authors
The 25 scholars most cited alongside David A. Eberhard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mutations in the Epidermal Growth Factor Receptor and in KRAS Are Predictive and Prognostic Indicators in Patients With Non–Small-Cell Lung Cancer Treated With Chemotherapy Alone and in Combination With Erlotinib Hit paper breakdown → | 2005 | 1260 |
| 2 | Diverse somatic mutation patterns and pathway alterations in human cancers Hit paper breakdown → | 2010 | 891 |
| 3 | Phase I/II Trial Evaluating the Anti-Vascular Endothelial Growth Factor Monoclonal Antibody Bevacizumab in Combination With the HER-1/Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib for Patients With Recurrent Non–Small-Cell Lung Cancer Hit paper breakdown → | 2005 | 488 |
| 4 | 2005 | 443 | |
| 5 | 2005 | 397 | |
| 6 | 1997 | 286 | |
| 7 | 2008 | 264 | |
| 8 | 1988 | 224 | |
| 9 | Complete inhibition of rhabdomyosarcoma xenograft growth and neovascularization requires blockade of both tumor and host vascular endothelial growth factor. | 2000 | 210 |
| 10 | 2006 | 207 | |
| 11 | 1990 | 204 | |
| 12 | 2013 | 198 | |
| 13 | 1989 | 193 | |
| 14 | 2017 | 144 | |
| 15 | Prostate stem cell antigen as therapy target: tissue expression and in vivo efficacy of an immunoconjugate. | 2002 | 125 |
| 16 | 1987 | 122 | |
| 17 | 2012 | 112 | |
| 18 | 2013 | 110 | |
| 19 | Alterations of annexin expression in pathological neuronal and glial reactions. Immunohistochemical localization of annexins I, II (p36 and p11 subunits), IV, and VI in the human hippocampus. | 1994 | 105 |
| 20 | 2009 | 105 |
About David A. Eberhard
David A. Eberhard is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Genetics, Molecular Biology and Cell Biology, having authored 51 papers that have together received 7.1k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (9 papers), Lung Cancer Treatments and Mutations (8 papers), Protein Kinase Regulation and GTPase Signaling (3 papers), AI in cancer detection (3 papers), Cellular transport and secretion (3 papers), Glioma Diagnosis and Treatment (3 papers), Breast Cancer Treatment Studies (3 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.1k citations), Genetics (447 citations), Cancer Research (666 citations), Oncology (1.1k citations) and Cell Biology (455 citations). David A. Eberhard has collaborated with scholars based in United States, Canada and Ireland. Frequent co-authors include Ronald W. Holz, Bruce Evan Johnson, Somasekar Seshagiri, Lukas C. Amler, Thomas Januario, Jeremy Stinson, Ladislau E. Steiner, Roy S. Herbst, Bernard F. Schneider and David H. Johnson. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Applied immunohistochemistry & molecular morphology, Nature and Biochemical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.